Prospective Biomarker Trials Chemo N0 and NNBC-3 Europe Validate the Clinical Utility of Invasion Markers uPA and PAI-1 in Node-Negative Breast Cancer.
Harbeck
Nadia
N
Frauenklinik und Poliklinik der Technischen Universität München, Germany.
Schmitt
Manfred
M
Vetter
Martina
M
Krol
Janna
J
Paepke
Daniela
D
Uhlig
Mathias
M
Paepke
Stefan
S
Jänicke
Fritz
F
Geurts-Moespot
Anneke
A
von Minckwitz
Gunter
G
Sweep
Fred
F
Thomssen
Christoph
C
Int J Oncol. 2003 Dec;23(6):1715-26
14612946
Lancet. 1989 Oct 28;2(8670):1049
2572788
Int J Biol Markers. 2003 Jul-Sep;18(3):207-17
14535592
Ann Oncol. 2005 Oct;16(10):1569-83
16148022
Clin Cancer Res. 2001 Aug;7(8):2448-57
11489825
J Clin Oncol. 2007 Nov 20;25(33):5287-312
17954709
Thromb Haemost. 2004 Mar;91(3):450-6
14983219
J Clin Oncol. 2006 Dec 20;24(36):5664-71
17116941
Cancer Res. 2000 Feb 1;60(3):636-43
10676647
Clin Cancer Res. 1998 Jan;4(1):177-82
9516968
Int J Cancer. 1997 Jul 3;72(1):1-22
9212216
J Natl Cancer Inst. 2001 Jun 20;93(12):913-20
11416112
J Natl Cancer Inst. 1996 Oct 16;88(20):1456-66
8841020
J Clin Oncol. 2003 Mar 15;21(6):1022-8
12637466
Cancer. 1988 Aug 1;62(3):531-3
3134120
J Clin Oncol. 2002 Feb 15;20(4):1000-7
11844823
Br J Cancer. 1998 Dec;78(11):1434-41
9836475
Cancer Res. 2002 Aug 15;62(16):4617-22
12183417
J Natl Cancer Inst. 2002 Jan 16;94(2):116-28
11792750
Int J Biol Markers. 2003 Apr-Jun;18(2):106-15
12841679
Semin Thromb Hemost. 1991 Jul;17(3):303-12
1796300